Format

Send to

Choose Destination
J Alzheimers Dis. 2016 Feb 26;52(1):25-31. doi: 10.3233/JAD-150922.

Diversity of Cognitive Phenotypes Associated with C9ORF72 Hexanucleotide Expansion.

Author information

1
Department of Neurology, Fundación Jiménez Díaz, Madrid, Spain.
2
Department of Neurology, Hospital Infanta Elena, Madrid, Spain.
3
Department of Neurology, Hospital Severo Ochoa, Madrid, Spain.
4
Department of Neurology, Hospital Virgen del Rocío, Seville, Spain.
5
Department of Genetics, Fundación Jiménez Díaz, Madrid, Spain.
6
Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD) and CIBERER, Madrid, Spain.
7
Secugen S.L., Madrid, Spain.

Abstract

For diagnostic purposes, we screened for the C9ORF72 mutation in a) 162 FTLD cases, and b) 145 cases with other diagnoses but with some frontotemporal features or manifestations previously reported in C9 carriers. Ten cases (onset 50 to 75 years) harbored the expansion: seven had FTLD syndromes (4.3% of total, 11% of familial cases), and three (2%) had a different diagnosis. All positive cases had family history of dementia, psychiatric disease, or ALS, but only 20% of families with mixed FTLD/ALS phenotypes carried the expansion. Language impairment was the most common symptom, followed by behavioral changes, memory deficits, and parkinsonism. C9ORF72 mutation has a low frequency in our dementia series and very diverse clinical manifestations.

KEYWORDS:

C9ORF72 gene; frontotemporal dementia; hexanucleotide expansion

PMID:
26967212
DOI:
10.3233/JAD-150922
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for IOS Press
Loading ...
Support Center